by Extivita | Jun 8, 2017 | Traumatic Brain Injury (TBI)
Abstract: Erythropoietin (EPO) may reduce mortality after traumatic brain injury (TBI). Secondary brain injury is exacerbated by multiple trauma, and possibly modifiable by EPO. We hypothesized that EPO decreases mortality more in TBI patients with multiple trauma,...
by Extivita | Nov 15, 2013 | Cancer
Abstract: Despite its high prevalence, anemia often does not receive proper clinical attention, and detection, evaluation, and management of iron deficiency anemia and iron-restricted erythropoiesis can possibly be an unmet medical need. A multidisciplinary panel of...
by Extivita | Jun 4, 2009 | Chronic Heart Failure
Abstract: The most important predictors of long-term survival in patients with cardiac ischemic disease are left ventricular ejection fraction, left ventricular volumes, infarction size, presence and extent of residual myocardial ischemia. One of the most important...
by Extivita | Sep 15, 2007 | Chronic Heart Failure
Abstract: The aim of this research is to evaluate therapy efficiacy of hyperbaric oxgenation (HBO) with regenerative effects on human tissues and erythropoietin, as a nonspecific growth factor. This study included a group of 9 patients with echocardiographically...
by Extivita | Mar 21, 2007 | Spinal Cord Injuries
Abstract: Recent studies have suggested that the brain preconditioning could induce tolerance to ischemia in humans. It has been believed that newly synthesized proteins are required for the acquisition of delayed tolerance in the brain and spinal cord. However, the...
